Lexaria Bioscience (LEXX) Earnings Date & Reports

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LEXX is expected to report earnings to fall 31.76% to -14 cents per share on October 29

Lexaria Bioscience LEXX Stock Earnings Reports

Q3'25

Est.

$-0.14

Q2'25

Missed

by $0.05

Q1'25

Est.

$-0.17

Q4'24

Missed

by $0.08

Q3'24

Missed

by $0.02

The last earnings report on July 18 showed earnings per share of -20 cents, missing the estimate of -15 cents. With 250.46K shares outstanding, the current market capitalization sits at 16.46M.

View a ticker or compare two or three

Compare

LEXX